Expertise in
1
conditions

Zhaozhong H. Cheng

Qingdao, CN 
Expertise in
1
conditions
Qingdao, CN 

Overview

Zhaozhong Cheng practices practicing medicine in Qingdao, China.

Cheng is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Roseola, Pulmonary Embolism, Pulmonary Hypertension, Solitary Fibrous Tumor, and Angioplasty.

They are actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 2 clinical trials.

Locations

Qingdao, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Drug
Study Drug: UT-15C
Study Phase: Phase 3
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

19 Total Publications

Corrigendum to "Epidemiology of pulmonary embolism in China, 2021: a nationwide hospital-based study", [The Lancet Regional Health - Western Pacific, Volume 54, January 2025, 101258].
Corrigendum to "Epidemiology of pulmonary embolism in China, 2021: a nationwide hospital-based study", [The Lancet Regional Health - Western Pacific, Volume 54, January 2025, 101258].
Journal: The Lancet regional health. Western Pacific
Published: February 03, 2025

Frequently Asked Questions about Zhaozhong H. Cheng

Is Zhaozhong H. Cheng a top-rated expert for Roseola?

MediFind is an objective health platform that identifies experts based on real-world data. Zhaozhong H. Cheng is classified as an Advanced expert for Roseola, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Zhaozhong H. Cheng participate in research or clinical trials?

Yes. Zhaozhong H. Cheng has published 19 articles and abstracts on conditions like Roseola. You can view a list of Zhaozhong H. Cheng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Cheng's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile